Abstract
Many clinicians believe hypercortisolism is ulcerogenic. However, data from clinical studies show that prophylaxis for peptic ulcer disease is no longer recommended in patients receiving corticosteroid treatment. This has not yet been verified in endogenous hypercortisolism by controlled clinical studies. The purpose of the current study was to evaluate the relationship between endogenous Cushing’s syndrome (CS) and peptic ulcer disease and Helicobacter pylori infection. The study group contained 20 cases with CS resulting from ACTH-dependent endogenous hypercortisolism. The control groups consisted of 14 age- and gender-matched cases receiving exogenous corticosteroid therapy and 100 cases of dyspepsia with non-cushingoid features. Upper gastrointestinal endoscopy was performed on all cases. Biopsies were taken from five different points: two samples from the antrum, two samples from the corpus, and one sample from the fundus. A histological diagnosis of Helicobacter pylori infection was also obtained from evaluation of biopsy specimens. The frequency of stomach and duodenal ulcers did not vary between the groups (p = 0.5 and p = 0.7). Antral gastritis was less frequent and pangastritis was more common in cases with CS compared to the healthy controls (p = 0.001 and p < 0.001). The incidence of Candida esophagitis was more frequent in cases with CS compared to cases with corticosteroid treatment and healthy controls (p = 0.03). Histopathological findings and frequency of Helicobacter pylori based on pathology results did not vary between the three groups. It is possible that neither exogenous nor endogenous corticosteroid excess directly causes peptic ulcer or Helicobacter pylori infection. Prophylactic use of proton pump inhibitors is not compulsory for hypercortisolism of any type.
Similar content being viewed by others
References
X. Bertagna, L. Guignat, L. Groussin, J. Bertherat, Cushing’s disease. Best Pract. Res. Clin. Endocrinol. Metab. 23(5), 607–623 (2009). doi:10.1016/j.beem.2009.06.001
E. Valassi, I. Crespo, A. Santos, S.M. Webb, Clinical consequences of Cushing’s syndrome. Pituitary 15(3), 319–329 (2012). doi:10.1007/s11102-012-0394-8
G. Arnaldi, T. Mancini, G. Tirabassi, L. Trementino, M. Boscaro, Advances in the epidemiology, pathogenesis, and management of Cushing’s syndrome complications. J. Endocrinol. Invest. 35(4), 434–448 (2012)
B. Swearingen, N. Wu, S.Y. Chen, S. Pulgar, B.M. Biller, Health care resource use and costs among patients with cushing disease. Endocr. Pract. 17(5), 681–690 (2011). doi:10.4158/ep10368.or
M.S. Broder, M.P. Neary, E. Chang, D. Cherepanov, W.H. Ludlam, Burden of illness, annual healthcare utilization and costs associated with commercially insured patients with cushing’s disease in the United States. Endocr. Pract. (2014). doi:10.4158/ep14126.or
H.O. Conn, B.L. Blitzer, Nonassociation of adrenocorticosteroid therapy and peptic ulcer. N. Engl. J. Med. 294(9), 473–479 (1976). doi:10.1056/nejm197602262940905
J. Messer, D. Reitman, H.S. Sacks, H. Smith Jr, T.C. Chalmers, Association of adrenocorticosteroid therapy and peptic-ulcer disease. N. Engl. J. Med. 309(1), 21–24 (1983). doi:10.1056/nejm198307073090105
H.O. Conn, T. Poynard, Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroid therapy. J. Intern. Med. 236(6), 619–632 (1994)
M. Guslandi, Steroid ulcers: any news? World J. Gastrointest. Pharmacol. Ther. 4(3), 39–40 (2013). doi:10.4292/wjgpt.v4.i3.39
T.P. Dorlo, N.G. Jager, J.H. Beijnen, J.H. Schellens, Concomitant use of proton pump inhibitors and systemic corticosteroids. Ned. Tijdschr. Geneeskd. 157(19), A5540 (2013)
L.K. Nieman, B.M. Biller, J.W. Findling, J. Newell-Price, M.O. Savage, P.M. Stewart, V.M. Montori, The diagnosis of Cushing’s syndrome: an Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 93(5), 1526–1540 (2008). doi:10.1210/jc.2008-0125
M.F. Dixon, R.M. Genta, J.H. Yardley, P. Correa, Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am. J. Surg. Pathol. 20(10), 1161–1181 (1996)
M. Rugge, R.M. Genta, Staging and grading of chronic gastritis. Hum. Pathol. 36(3), 228–233 (2005). doi:10.1016/j.humpath.2004.12.008
M. Guslandi, A. Tittobello, Steroid ulcers: a myth revisited. BMJ 304(6828), 655–656 (1992)
M. de Carpani Kaski, R. Rentsch, S. Levi, H.J. Hodgson, Corticosteroids reduce regenerative repair of epithelium in experimental gastric ulcers. Gut 37(5), 613–616 (1995)
J.C. Luo, V.Y. Shin, E.S. Liu, W.H. So, Y.N. Ye, F.Y. Chang, C.H. Cho, Non-ulcerogenic dose of dexamethasone delays gastric ulcer healing in rats. J. Pharmacol. Exp. Ther. 307(2), 692–698 (2003). doi:10.1124/jpet.103.055202
J.C. Luo, V.Y. Shin, E.S. Liu, Y.N. Ye, W.K. Wu, W.H. So, F.Y. Chang, C.H. Cho, Dexamethasone delays ulcer healing by inhibition of angiogenesis in rat stomachs. Eur. J. Pharmacol. 485(1–3), 275–281 (2004)
J. Martinek, K. Hlavova, F. Zavada, B. Seifert, S. Rejchrt, O. Urban, M. Zavoral, “A surviving myth”—corticosteroids are still considered ulcerogenic by a majority of physicians. Scand. J. Gastroenterol. 45(10), 1156–1161 (2010). doi:10.3109/00365521.2010.497935
G.H. Elta, H.D. Appelman, E.M. Behler, J.A. Wilson, T.J. Nostrant, A study of the correlation between endoscopic and histological diagnoses in gastroduodenitis. Am. J. Gastroenterol. 82(8), 749–753 (1987)
L. Atkins, E.B. Benedict, Correlation of gross gastroscopic findings with gastroscopic biopsy in gastritis. N. Engl. J. Med. 254(14), 641–644 (1956). doi:10.1056/nejm195604052541403
N.J. Carr, H. Leadbetter, A. Marriott, Correlation between the endoscopic and histologic diagnosis of gastritis. Ann. Diagn. Pathol. 16(1), 13–15 (2012). doi:10.1016/j.anndiagpath.2011.08.002
J.N. Aucott, Glucocorticoids and infection. Endocrinol. Metab. Clin. North Am. 23(3), 655–670 (1994)
Y.S. Sari, E. Sander, E. Erkan, V. Tunali, Endoscopic diagnoses and CLO test results in 9239 cases, prevalence of Helicobacter pylori in Istanbul, Turkey. J. Gastroenterol. Hepatol. 22(11), 1706–1711 (2007). doi:10.1111/j.1440-1746.2006.04610.x
I. Baricevic, O. Nedic, J.A. Nikolic, B. Bojic, N. Jojic, Circulating insulin-like growth factors in patients infected with Helicobacter pylori. Clin. Biochem. 37(11), 997–1001 (2004). doi:10.1016/j.clinbiochem.2004.07.007
B. Kosan, O. Yuksel, I. Ustun, S. Koklu, F. Topal, M. Yilmaz, B. Ergul, S. Karaahmetoglu, E. Eskioglu, E. Altiparmak, Role of endogenous cortisol on Helicobacter pylori colonization. Clin. Biochem. 41(10–11), 917–919 (2008). doi:10.1016/j.clinbiochem.2008.03.004
Acknowledgments
None.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hatipoglu, E., Caglar, A.S., Caglar, E. et al. Peptic ulcer disease in endogenous hypercortisolism: myth or reality?. Endocrine 50, 489–495 (2015). https://doi.org/10.1007/s12020-015-0608-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-015-0608-8